Cannabis News
Authoritative coverage of the global cannabis industry — regulation, investment, markets and policy, reported for the people who run it.
Cannabis News · page 100
- Policy & Regulation
New Cannabis Regulations in Bundestag: Traffic Rules, Cultivation Restrictions, and Training Programs
Written for Business of Cannabis by Prohibition Partners Senior Analyst Alex Khourdaji In the late evening of 16th May 2024, the Bundestag held its first reading of the first draft law to amend the Consumer Cannabis Act and the Medical Cannabis Act in the Bundestag as well as amendments to the Road Traffic Act.
- Data & Analysis
Cannabis Rescheduling ‘Likely’ to Take Place Before Presidential Election, Say Analysts
Cannabis rescheduling is ‘likely’ to take place before the upcoming presidential election, according to new analysis from the Bank of America.
- Pharmaceutical
Ex-GW Pharma Bosses Lead Development of New CBD-Based Epilepsy Drug
As reported by Cannabis Health Avata Biosciences is developing solid dose cannabinoid medicines for epilepsy and other neurological disorders, with a number of former GW Pharmaceutical bosses on board.
- Policy & Regulation
Cannabis Rescheduling Confirmed: DOJ Initiates Formal Rulemaking Process As Biden Makes it Official
President Joe Biden has officially confirmed that cannabis is set to be rescheduled from a Schedule I substance to a Schedule III.
- Uncategorized
Deutsche Ministerin signalisiert Ende der “sinnlosen” Rauschklausel als möglicher Segen für die Hanfindustrie
Der Bundesminister für Ernährung und Landwirtschaft hat angedeutet, dass die umstrittene Rauschmittelklausel in Deutschland bald abgeschafft werden könnte.
- Hemp Industry
German Minister Signals End of ‘Senseless’ Intoxication Clause in Potential Boon For Hemp Industry
Germany’s Federal Minister of Food and Agriculture has suggested that the country’s controversial ‘intoxication clause’ could soon be scrapped.
- Uncategorized
New York’s Embattled Cannabis Regulators Hit By Another Major Lawsuit
New York’s beleaguered cannabis regulators have been hit with another lawsuit that seeks to invalidate hundreds of licenses in the already underserved state.
- Press releases
Somaí Group, and Its Subsidiary, RPK Biopharma Expand Cookies Partnership to Include Europe and the UK
SOMAÍ Group (“SOMAÍ”) and its subsidiary, RPK Biopharma expanded their existing partnership with Cookies Creative Consulting & Promotions, Inc., a California corporation (“CCC&P”) to include additional territories for the dried flower portfolio and manufacture different extract products.
- Adult-Use
Cresco Labs Races to Meet Ohio’s Recreational Cannabis Demand Amid Supply Chain Concerns
Cresco Labs, one of the largest medical cannabis producers in Ohio, has planted its first crop of nearly 1000 cannabis plants specifically meant for the recreational market, which could potentially open up in the coming weeks.
- Markets & Stocks
Cantourage & Celadon Announce Double Digit Growth in 2023, Hellenic Dynamics Announces Further Fundraise
Celadon Pharmaceuticals [stock_market_widget type=”chart” template=”line” assets=”CEL.L” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Celadon Pharmaceuticals this week released its full-year results for 2023, reporting revenues over three times those seen in 2022.
- Uncategorized
Organigram’s Q2 Figures Hit By Lower International Sales
As earnings season gets into full swing, Canada’s Organigram has become the latest major cannabis operator to publish its financial performance figures.
- Companies
Oxford Cannabinoid Technologies Delisting From LSE May Not ‘Be The Last’
Last week, UK biotechnology firm Oxford Cannabinoid Technologies (OCT), one of the first cannabis companies in history to list on the London Stock Exchange (LSE), informed investors of its intention to leave.
